Skip to main content
. 2019 Apr 18;13(5):1249–1267. doi: 10.1002/1878-0261.12483

Figure 7.

Figure 7

Schematic representation of miR‐122‐mediated radioresistance in breast cancer cells. miR‐122 has an oncogenic role in the acquired radioresistance of luminal and TNBC cells by differentially controlling the expression of ZNF611 and ZNF304 transcription factors, as well as modulating the expression of genes involved in RAS‐MAPK and TNF pathways to promote survival.